Becton Dickinson & Company recalls BD Posiflush SF Saline Flush Syringe (US Distributed Catalog 306553), UDI 50382903065535

Recall date

April 16, 2020

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

Z-2065-2020

FDA classification

Class II

Brand / firm

Becton Dickinson & Company

Sold / distributed

Nationwide domestic distribution. Foreign distribution to Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK, Australia, Canada, Mexico, Malaysia, New Zealand

Why it was recalled

This product has been confirmed to exhibit holes in the packaging, which impacts package integrity and potentially compromises a sterile field.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

BD Posiflush SF Saline Flush Syringe (US Distributed Catalog 306553), UDI 50382903065535